| Serial Number | 87695246 |
| Word Mark | SYNTHORIN |
| Filing Date | Wednesday, November 22, 2017 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, January 31, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 30, 2018 |
| Goods and Services | protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, and infectious diseases; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from cancer and autoimmune disorders; Protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, therapeutic agents in the nature of cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, anti-infectives, analgesics, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 5, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Synthorx, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | La Jolla, CA 92037 |
| Party Name | Synthorx, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | La Jolla, CA 92027 |
| Event Date | Event Description |
| Monday, January 31, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, January 31, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, May 18, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, May 17, 2021 | SOU EXTENSION 5 GRANTED |
| Wednesday, May 5, 2021 | SOU EXTENSION 5 FILED |
| Monday, May 17, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, May 5, 2021 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 5, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 3, 2020 | SOU EXTENSION 4 GRANTED |
| Tuesday, November 3, 2020 | SOU EXTENSION 4 FILED |
| Tuesday, November 3, 2020 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 11, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 9, 2020 | SOU EXTENSION 3 GRANTED |
| Tuesday, June 9, 2020 | SOU EXTENSION 3 FILED |
| Tuesday, June 9, 2020 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 10, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, February 10, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, February 7, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, February 7, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, December 13, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 11, 2019 | SOU EXTENSION 2 GRANTED |
| Wednesday, December 11, 2019 | SOU EXTENSION 2 FILED |
| Wednesday, December 11, 2019 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 20, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 18, 2019 | SOU EXTENSION 1 GRANTED |
| Tuesday, June 18, 2019 | SOU EXTENSION 1 FILED |
| Tuesday, June 18, 2019 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 25, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, October 30, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 30, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 10, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sunday, September 23, 2018 | ASSIGNED TO LIE |
| Monday, September 10, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, September 6, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, September 6, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, September 6, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, September 6, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, March 7, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 7, 2018 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 7, 2018 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 7, 2018 | ASSIGNED TO EXAMINER |
| Tuesday, December 5, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, November 25, 2017 | NEW APPLICATION ENTERED |